Header Logo

Search Results (289)

MatchTypeWhy
Kalantar-Zadeh M.D., KamyarPerson Why?
Apabetalone lowers serum alkaline phosphatase and improves cardiovascular risk in patients with cardiovascular disease.Academic Article Why?
Handelsman, YehudaPerson Why?
Cardiovascular and Renal Outcomes Trials-Is There a Difference?Academic Article Why?
The Obesity Paradigm and Lifetime Risk of Cardiovascular Disease.Academic Article Why?
The quest for cardiovascular disease risk prediction models in patients with nondialysis chronic kidney disease.Academic Article Why?
Vitamin D and the cardiovascular system.Academic Article Why?
Risk of Atherosclerotic Cardiovascular Disease and Nonatherosclerotic Cardiovascular Disease Hospitalizations for Triglycerides Across Chronic Kidney Disease Stages Among 2.9?Million US Veterans.Academic Article Why?
Alkaline phosphatase: better than PTH as a marker of cardiovascular and bone disease?Academic Article Why?
Cardiovascular disease control through barbershops: design of a nationwide outreach program.Academic Article Why?
Childhood antecedents to adult cardiovascular disease.Academic Article Why?
Comparative risk of renal, cardiovascular, and mortality outcomes in controlled, uncontrolled resistant, and nonresistant hypertension.Academic Article Why?
Comprehensive diabetes cardiovascular treatment = sugar + blood pressure + lipids.Academic Article Why?
Fetal catecholamine, cardiovascular, and neurobehavioral responses to cocaine.Academic Article Why?
Glycemia and risk for cardiovascular disease.Academic Article Why?
Per Page    Page  of 20last Nextnext
Prev
Search Criteria
  • cardiovascular
Filter by Type
_
Click "Why?" to see why an item matched the search.